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Abstract
The Rho‐kinase (ROCK) family members, consisting of ROCK1 and ROCK2, are serine‐
threonine kinases that are activated by small GTPases. ROCKs play central roles in the 
actin cytoskeleton organization and regulate a wide range of fundamental cellular func‐
tions, such as apoptosis, inflammatory responses, cell contractility, adhesion, migration, 
motility, proliferation, phagocytosis, and apoptosis. Accumulating evidence from basic 
and clinical studies supports the concept that ROCK plays important roles in many dis‐
eases and could be a potential therapeutic target for diverse disorders, including cardio‐
vascular, neurologic, metabolic, autoimmune disorders, and cancers. Although there are 
only limited numbers of published studies related to ROCK polymorphisms in humans, 
the contribution of the genetic studies related to ROCK variants to the disease states is 
emerging. Identifying mutated genes or associated polymorphisms and evaluating their 
potential risks are important steps for understanding the genetic components and patho‐
genesis of diseases. Identification of functional mutations or polymorphisms could poten‐
tially help in the development of novel ROCK‐specific therapies in related disease states.
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1. Introduction
Rho‐kinase (ROCK) is a serine/threonine kinase that is activated by small Rho GTPase pro‐
teins. Two ROCK isoforms have been identified: ROCK1 and ROCK2. These ROCK isoforms 
are encoded by separate genes on human chromosomes 18q11.1 (ROCK1) and 2p24 (ROCK2). 
ROCK1 and ROCK2 enzymes contain 1354 and 1388 amino acids, respectively [1, 2]. Two iso‐
forms have ∼65% overall amino acid homology and ∼92% homology in the kinase domain. The 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
carboxy terminus of ROCK folds back onto the kinase domain, thereby forming an autoinhibi‐
tory loop that maintains the enzyme in an inactive state. Binding of GTP‐bound, biochemically 
active Rho (such as RhoA/RhoB/RhoC) to the Rho‐binding domain (RBD) disrupts the negative 
regulatory interaction between the catalytic domain and the autoinhibitory C‐terminal region, 
resulting in activation of the enzyme in response to extracellular signals [1, 2]. On the other 
hand, RhoE interacts with the N‐terminal region of ROCK1 and prevents Rho binding to RBD 
[3]. ROCK1 is cleaved by caspase‐3, but ROCK2 can be cleaved by granzyme B or caspase‐2 
(Figure 1) [1, 2]. ROCK enzymes are likely to exist as dimers by parallel association at the 
coiled‐coil domain and the dimerized kinase domain of ROCK appears to be in an active con‐
formation in the absence of phosphorylation [4, 5].
Although ROCK1 and ROCK2 are ubiquitously expressed, ROCK2 is highly expressed in 
the brain and the heart, whereas ROCK1 is preferentially expressed in the lung, liver, spleen, 
kidney, and testis [1, 6]. ROCK signaling has been implicated in a wide range of fundamental 
cellular functions including cell morphology, contraction, adhesion, motility, migration, pro‐
liferation, differentiation, invasion, metastasis, and apoptosis [1, 2]. ROCK can also regulate 
macrophage phagocytic activity and endothelial cell permeability, and it is known to play a 
role in inflammatory mechanisms and endothelial dysfunction [7, 8].
2. ROCK polymorphisms and disease susceptibility
There are only limited numbers of published studies related to ROCK polymorphisms in 
humans. However, the contribution of the genetic studies related to ROCK variants to the 
disease states is emerging.
Figure 1. Schematic molecular structure and main regulators of ROCKs. ROCK sequences comprise a kinase domain 
located at the amino terminus of the protein, followed by a coiled‐coil region containing the Rho‐binding domain (RBD) 
and a pleckstrin homology (PH) domain with a cysteine‐rich domain (CRD).
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2.1. Cancer
It has been demonstrated that ROCK2 gene rs2230774 (Thr431Asn), but not rs1130757 
(Arg83Lys), polymorphism is significantly associated with metastases of breast cancer [9]. 
Although homozygous carriers of the Thr431Thr genotype were more frequent, heterozy‐
gous carriers of the Thr431Asn genotype were less frequent among the metastatic patients 
than among controls. There was also an increase in Thr431 allele and decrease in Asn431 
allele frequencies in patients with distant metastases. Furthermore, increased Thr431Thr 
genotype and Thr431 allele frequencies were found to be associated with negative estro‐
gen and progesterone receptor status in the metastatic group [9]. This data suggest that 
Thr431Asn polymorphism of the ROCK2 gene is a risk factor for the metastases of the breast 
cancer, and may help in predicting the prognosis. Indeed, activating ROCK1 mutations 
(Y405*, S1126*, and P1193S) that increase cellular motility through actin cytoskeleton rear‐
rangement have been identified in breast and lung carcinomas [10]. The Y405* and S1126* 
mutants, which lead to premature termination of translation at Tyr405 and Ser1126, were 
both identified in primary human breast cancers, whereas the third mutation, P1193S, which 
leads to a substitution of proline 1193 with serine, was identified from the established human 
non‐small‐cell lung carcinoma line NCI‐H1770. rs11874761 rs8085504 rs2127958 rs17202375 
rs288980 polymorphisms of the ROCK1 gene were studied in patients with non‐small cell 
lung cancer, but no association was observed [11]. Thus, no evidence was found to suggest 
that these polymorphisms play a significant role in lung cancer susceptibility [11]. Recently, 
a nonsense mutation (G285*) in ROCK1 that introduces a premature stop codon at amino 
acid 285, and a ROCK2 mutation (S457N) has been identified in gastric cancer patients with 
peritoneal carcinomatosis [12]. Collectively, these results may suggest the importance of the 
ROCK gene in breast, lung, and gastric carcinomas.
There are some controversial results about the association between the ROCK polymorphisms 
and colorectal carcinoma. Significant associations between ROCK1 (rs73963110 and rs35996865) 
and ROCK2 gene polymorphisms (rs2290156, rs10178332, rs35768389, rs10929732 and 
rs34945852) with colorectal cancer development have been detected [13]. However, no marked 
associations were found between ROCK2 gene rs965665, rs2230774, rs6755196, and rs1515219 
polymorphisms and the risk of developing colorectal cancer [13]. ROCK and p53 immuno‐
histochemical stainings were found to be markedly elevated in the tumor tissue. There were 
also significant correlations between vascular and perineural invasions with ROCK2 or p53 
protein expressions [13]. These data showed that the ROCK1 and ROCK2 genes might be a risk 
factor for colorectal cancer development, and that genetic polymorphism in these genes may 
modify individual susceptibility to colorectal cancer in the Turkish population [13]. However, 
none of the allelic or genotypic variants of the four ROCK1 (rs35996865, rs73963110, rs2127958, 
and rs288980) and five ROCK2 (rs12692437, rs7563468, rs35768389, rs17463896, and rs16857265) 
polymorphisms was found to be associated with the occurrence of colorectal cancer or with the 
development of regional lymph node metastasis in an Italian population [14]. It is noteworthy 
that no evidence of an association was found for ROCK2 rs35768389 or for ROCK1 rs73963110 
variants, which have been previously described as relevant to colorectal cancer development in 
a Turkish cohort [13]. On the other hand, Zucchini et al. [14]. found that the ROCK1 rs35996865 
G variant allele was significantly more frequent in male patients than in the control group. This 
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finding points to a possible gender‐related modulation by the ROCK1 gene in colorectal cancer 
susceptibility.
Although there were no significant associations between ROCK2 gene polymorphisms 
[rs2290156, rs965665, rs10178332, rs2230774 (Thr431Asn), rs2230774 (Thr431Ser), rs6755196, 
and rs726843] and mantle cell lymphoma cases, ROCK1 protein and gene expressions were 
markedly increased in lymph node tissues of the patients [15]. Demonstration of no signifi‐
cant associations between ROCK2 gene polymorphisms and mantle cell lymphoma cases may 
be due to the differences in pathogenesis between different types of cancer as well as the small 
number of cases in this study [15].
ROCK1 gene rs35996865 polymorphism was significantly associated with the increasing risk 
of clear cell renal cell carcinoma in a Chinese population [16]. However, no significant associa‐
tions were found with ROCK1 gene rs8089974 and rs11874761 polymorphisms. Results of this 
study indicate that the risk of clear cell renal cell carcinoma is increased in participants with 
G allele of rs35996865.
2.2. Cardiovascular diseases
Seasholtz et al. [17] reported that rs2230774 (Thr431Asn) polymorphism at ROCK2 gene 
predicts increased blood pressure, systemic vascular resistance, and resistance in response 
to the endogenous renin‐angiotensin system in twins. The Asn/Asn genotype was associ‐
ated with a greater resting systolic, diastolic, and mean blood pressures. Systemic vascular 
resistance was found to be higher in Asn/Asn individuals, and aldosterone secretion was 
lowest in Asn/Asn homozygotes [17]. Rankinen et al. [18] showed that a major haplotype 
block at the ROCK2 locus (containing the minor alleles of rs965665, rs10178332, rs6755196, 
and rs10929732) is recessively associated with a lower risk of hypertension. However, it has 
been shown that ROCK2 Thr431Asn polymorphism does not exhibit any significant allele 
or genotype association with hypertension in a Chinese Han population [19]. Consistently, 
another Chinese population study did not detect the association between ROCK2 gene poly‐
morphisms and hypertension [20]. Liu et al. [20] tested the association between coronary 
artery disease and ROCK2 gene rs978906, rs2230774 (Thr431Asn), rs56304104 polymor‐
phisms, but no significant association was detected in a Chinese population. This study also 
does not support a major role for these three ROCK2 polymorphisms in determining blood 
pressure levels. Thus, results of this analysis do not support common variants in the coding 
region of ROCK2 to have a major effect to coronary artery disease susceptibility.
Significant associations were observed for GG genotype of rs978906, AA genotype of rs6753921, 
GG genotype of rs10495582, and AA genotype of rs2230774 (Thr431Asn) polymorphisms with 
high‐altitude essential hypertension in Indian high‐altitude native Ladakhi population [21]. 
Haplotype GAGA composed of variant alleles was found to be in higher proportion in cases 
[21]. Other six polymorphisms (rs2290156, rs10167277, rs10929727, rs6716817, rs4477886, 
and rs10929728) were also studied, but no marked changes were noted in this study [21]. 
Associations of ROCK2 gene polymorphisms with elevated systolic blood pressure levels sug‐
gest the involvement of these four polymorphisms in high‐altitude essential hypertension.
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Peterson et al. [22] evaluated allelic variants [rs12622447, rs10929728, rs1868584, rs6716817, 
rs2230774 (Thr431Asn), rs5829297, rs4027164, and rs17366517] or haplotypic associations of 
ROCK2 in women with preeclempsia in a Finnish population and did not detect any signifi‐
cant association, implying that ROCK2 gene could not be a functional target for the regulation 
of preeclempsia. It is concluded that common genetic variations in ROCK2 are unlikely to 
make a major contribution to the risk of preeclampsia in the Finnish population. However, 
ROCK2 gene intronic rs1868584 variant is reported to be associated with cardiovascular dis‐
ease and hypertension [23].
The major alleles of rs978906 (A allele) and rs2230774 (C allele) of ROCK2 gene were found to 
be significantly associated with arterial stiffness in a Chinese population residing in Taiwan 
[24]. They found that the A allele of rs978906 has reduced repression of miR‐1183 resulting in 
significantly higher ROCK2 expression levels than the G allele. It has been proposed that peo‐
ple carrying the A allele are prone to arterial stiffness because their ROCK2 levels tend to be 
high [24]. Thus, these two functional polymorphisms of ROCK2 gene can increase the suscep‐
tibility of arterial stiffness by affecting ROCK2 levels and activity in the Chinese population.
Yoo et al. [25] demonstrated that the genotype frequencies of five polymorphisms (rs978906, 
rs2271621, rs2230774, rs1515219 and rs3771106) of ROCK2, in the vasospastic angina group, 
were not significantly different from that in the control group in the Korean population. The 
only marked difference was noted in haplotype analysis [25]. The haplotype GTCTG was sig‐
nificantly associated with a decreased risk of vasospastic angina, suggesting that the ROCK2 
gene might be involved in the pathogenesis of vasospastic angina in the Korean population.
No association of the ROCK2 gene rs2230774 (Thr431Asn) polymorphism with the development 
of cardiac septal defects in pediatric patients has been reported [26], suggesting that this poly‐
morphism is not a contributing factor to the susceptibility of atrial or ventricular septal defects.
Palomino Doza et al. [27] investigated the role of genetic variations in ROCK1 on the risk of 
tetralogy of Fallot in British Caucasian patients, and found that ROCK1 gene rs288979 and 
rs56085230 (Tyr269Tyr) variants were significantly associated with tetralogy of Fallot. In 
this study, ROCK1 gene rs2292296 (Leu1097Phe), rs7237677, rs7227454, rs288989, rs45449301 
(Ile432Val), rs288979, rs17202368, rs17202375, rs2271255 (Lys222Glu), rs1481280, rs8085504, 
rs398528, rs112165707 (Ser595Ser), and rs45562542 (Thr773Ser) polymorphisms were also 
studied, but no significant changes were determined [27].
2.3. Autoimmune diseases
Significant differences between systemic sclerosis patients and control group were observed 
with regard to rs35996865 polymorphism of the ROCK1 gene and rs10178332 polymorphism of 
the ROCK2 gene [28]. CC genotype frequency of the rs35996865 polymorphism was found to be 
extremely low in patients with Raynaud’s phenomenon [28]. A significant difference between 
systemic sclerosis patients and control group was observed in G allele and GG genotype distri‐
butions of alteration in the ROCK2 gene rs10178332 polymorphism. Additionally, GG allele fre‐
quency was significantly low in patients with Raynaud’s phenomenon and lung involvement 
[28]. In this study, rs112108028 (Pro1164Leu) and rs1045144 for ROCK1; rs2230774 (Thr431Ser), 
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rs2230774 (Thr431Asn), rs35768389 (Asp601Val), rs726843, rs2290156, rs965665, rs6755196, and 
rs10929732 for ROCK2 gene polymorphisms were also examined, but no marked associations 
were noted. These results strongly suggest that rs35996865 and rs10178332 polymorphisms 
may be important risk factors for the development of systemic sclerosis.
It has been reported that ROCK2 gene rs35768389 (Asp601Val) polymorphism is associated 
with Behçet’s disease [29]. There are marked elevations in both TA genotype and A allele 
frequencies of this polymorphism in patients group. Although CC genotype of rs1515219 
polymorphism was more frequent, CT genotype was less frequent among the patients with 
Behçet’s disease. There was an increase in C allele frequency in patients [29]. Additionally, 
high AC and TT haplotype frequencies, and an increase in peripheral blood mRNA ROCK2 
gene expression were observed in cases with Behçet’s disease. However, no associations were 
found with rs726843, rs2290156, rs965665, rs10178332, rs2230774, rs6755196, rs10929732, and 
rs34945852 polymorphisms [29]. These results strongly suggest that ROCK2 gene polymor‐
phisms may act as a contributing factor to the individual susceptibility of Behçet’s disease.
ROCK1 gene polymorphisms may also have a significant impact on susceptibility to Behçet’s 
disease. In the presence of CC genotype for rs73963110, CT genotype for rs111874856 (Val355Ile), 
and TC genotype for rs112130712 (Lys1054Arg) polymorphisms, the risk of Behçet’s disease 
increased 12.13‐, 15.05‐, and 16.28‐fold, respectively [30]. A lower frequency of the GA geno‐
type of the rs112108028 (Pro1164Leu) polymorphism was associated with increased risk of 
Behçet’s disease. Moreover, all these polymorphisms showed marked associations with the 
manifestations of Behçet’s disease. Oguz et al. [30] showed that TC and CC genotypes and C 
allele of the rs73963110 polymorphism, TC genotype and C allele of the rs112130712 polymor‐
phism, CT genotype and T allele of the rs111874856 polymorphism, and GG genotype and G 
allele of the rs112108028 polymorphism may increase the susceptibility to Behçet’s disease. 
Although CTCG, CCTG, and TCTG haplotype frequencies were high in the patient group, 
TTCA haplotype frequency was low in Behçet’s disease. Interestingly, CCTG and TCTG hap‐
lotypes were absent in the control group, while they had 9.5 and 6.8% frequencies in cases 
with Behçet’s disease, respectively [30]. These two haplotypes can be advocated as a bio‐
marker for early prediction of developing Behçet’s disease in a Turkish population. However, 
no marked associations were detected between rs35996865, rs111312709 (Thr792Ala), and 
rs2271255 (Lys222Glu) polymorphisms and Behçet’s disease [30]. Taken together, these data 
showed that ROCK gene appears to be a risk factor for Behçet’s disease, and genetic polymor‐
phisms in ROCK genes modify individual susceptibility to Behçet’s disease. These findings 
may also provide important insight into the future development or use of potential therapeu‐
tic approaches, such as ROCK inhibitors, for patients with Behçet’s disease.
There is also evidence that ROCK2 gene intronic rs1868584 variant was shown to be associated 
with rheumatoid arthritis [23].
2.4. Ocular diseases
There are only two published association studies related to ROCK gene polymorphisms 
in ocular diseases. No evidence for an association of ROCK2 gene rs2230774 (Thr431Asn) 
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and rs1130757 (Arg83Lys) polymorphisms with diabetic retinopathy has been reported in a 
Turkish Population [31]. Additionally, the haplotypes are not significantly associated with 
diabetic retinopathy as shown in this study [31]. Moreover, another recent study demon‐
strated that the polymorphisms for the ROCK1 (rs35996865) and ROCK2 [rs2290156, rs965665, 
rs10178332, rs2230774 (Thr431Asn), rs2230774 (Thr431Ser), rs6755196, and rs726843] genes 
are not associated with the increased risk of development of primary open‐angle glaucoma in 
a Turkish population [32]. There were also no marked associations between the haplotype fre‐
quencies and primary open‐angle glaucoma. Collectively, these results suggest that studied 
ROCK1 and ROCK2 gene polymorphisms are not contributing factors to the susceptibility of 
diabetic retinopathy or primary open‐angle glaucoma.
2.5. Ischemic stroke
In a large prospective study, associations of ROCK1 gene variants with the risk of ischemic 
stroke have been observed in healthy Caucasian women [33]. Seven (rs7239317, rs2127958, 
rs1481280, rs1006881, rs11874761, rs10083915, and rs11873284) of the tagging single nucleo‐
tide polymorphisms evaluated in ROCK1 gene were associated significantly with the risk 
of ischemic stroke [33]. rs288980 polymorphism was also studied, but no marked associa‐
tion was observed. Thus, ROCK1 gene variation may influence the risk of ischemic stroke. 
In contrast, none of the polymorphisms (rs921322, rs8996, rs6753921, rs2230774, rs1515219, 
rs6716817, rs10203916, rs6755337, and rs12622447) in ROCK2 were associated with the risk of 
ischemic stroke [33]. These findings may highlight the potential prognostic utility of ROCK1‐
associated gene variation in the prediction of the risk of ischemic stroke.
2.6. Metabolic syndrome
ROCK1 gene rs35996865 polymorphism and ROCK2 gene rs2230774 (Thr431Asn) polymor‐
phism are markedly associated with the obesity‐related metabolic syndrome in a Turkish 
population [34]. However, no significant associations with the other 9 ROCK polymorphisms 
[ROCK1: rs73963110, rs112108028 (Pro1164Leu), and rs111312709 (Thr792Ala), ROCK2: 
rs2230774 (Thr431Ser), rs726843, rs2290156, rs965665, rs10178332, and rs6755196] have been 
observed [34]. These results suggest that CA and AA genotypes and A allele of the rs35996865 
polymorphism, and CC genotype and C allele of the rs2230774 (Thr431Asn) polymorphism 
may increase the individual susceptibility to metabolic syndrome.
2.7. Respiratory distress syndrome
There is evidence that ROCK1 gene rs2271255 (Lys222Glu) and rs35996865 polymorphisms, 
and ROCK2 gene rs726843, rs2290156, rs10178332, rs35768389 (Asp601Val) polymorphisms 
are significantly associated with respiratory distress syndrome, and that these polymor‐
phisms could be a risk factor for the development of neonatal respiratory distress syndrome 
[35]. High odds ratios were observed with these polymorphisms. However, no associations 
were found with rs73963110, rs1515219, rs965665, rs2230774 (Thr431Asn), rs6755196, and 
rs10929732 polymorphisms. Additionally, 12 haplotypes (6 in ROCK1 and 6 in ROCK2) were 
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found to be markedly associated with respiratory distress syndrome. Interestingly, TGCA 
and TGCT haplotypes were only observed among the cases. Although none of the controls 
had TGCT haplotype, it was seen in 26% of the infants with respiratory distress syndrome 
[35]. It should be emphasized that rs2271255 (Lys222Glu) and rs726843 polymorphisms have 
not been associated with any other disease yet. Collectively, these results strongly suggest 
that ROCK gene polymorphisms may modify individual susceptibility to respiratory distress 
syndrome in neonates.
2.8. Kidney disease
It has been demonstrated that rs2230774 (Thr431Asn) polymorphism of ROCK2 gene is sig‐
nificantly associated with chronic kidney disease in individuals with a low serum concentra‐
tion of triglycerides, with the A allele being protective against this condition [36]. Rao et al. 
[37] showed that rs1515219 and rs2290156 polymorphisms of the ROCK2 gene are associated 
with urinary albumin excretion in twin pairs.
2.9. Overactive bladder
Gurocak et al. [38] found that genotype and allele frequencies were not significantly different 
between the children with overactive bladder and the control group for ROCK2 gene rs2230774 
(Thr431Asn) polymorphism. It was concluded that this polymorphism has no impact on the 
response to anticholinergic treatment.
2.10. Epilepsy
Association of the Thr431Asn polymorphism with idiopathic generalized epilepsy has been 
investigated in a study [39]. Genotype distributions and the allele frequencies for the Thr431Asn 
polymorphism showed no significant differences between the control and epilepsy groups. 
Moreover, this polymorphism did not influence age of epilepsy onset, family history, single or 
combined drug treatments, or status epilepticus [39]. Therefore, these results suggest that the 
Asn431 ROCK2 variant allele is not an important risk factor for the development of idiopathic 
generalized epilepsy and does not influence the main clinical characteristics of idiopathic gen‐
eralized epilepsy.
2.11. Migraine
Uslu Kuzudisli et al. [40] have investigated the association of the Thr431Asn polymorphism 
with migraine in a Turkish population. No statistically significant association between a 
migraine and genotype distributions or the allele frequencies for the ROCK2 gene Thr431Asn 
polymorphism was demonstrated. In addition, there were no marked differences in genotype 
and allele frequencies for the migraine without aura and migraine with aura subgroups when 
compared with control group [40]. These findings suggest that the ROCK2 gene Thr431Asn 
polymorphism is not a risk factor for the migraine, and it is not involved in the migraine 
pathogenesis.
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2.12. Diabetes
It has been reported that ROCK2 gene rs2230774 (Thr431Asn) and rs1130757 (Arg83Lys) 
polymorphisms were not associated with the risk of diabetes (mainly type‐2) [31], suggest‐
ing that these polymorphisms are not a contributing factor to the susceptibility of diabetes in 
a Turkish population. However, Ross [23] presented evidence for the association of ROCK2 
rs1868584 variant with type‐1 diabetes.
2.13. High altitude pulmonary edema
Pandey et al. [41] investigated a total of 13 ROCK2 gene polymorphisms (rs978906, rs6753921, 
rs2290156, rs10495582, rs2230774, rs10167277, rs13393192, rs10929727, rs6716817, rs4477886, 
rs41264193, rs12622447, and rs10929728), but one polymorphism (rs10929728) emerged sig‐
nificant among the study groups. A significant association was observed for C allele of the 
rs10929728 with high altitude pulmonary edema [41]. Thus, an overrepresentation of ROCK2 
rs10929728C demonstrated the role of this allele in increasing the risk susceptibility to high 
altitude pulmonary edema. These data may suggest that stress‐activated ROCK2 gene has a 
role in predisposing an individual to high altitude pulmonary edema.
2.14. Psychiatric disorders
ROCK2 rs1868584 polymorphism was shown to be associated with bipolar disorder [23]. No 
associations between ROCK1 gene rs8085654, rs288980, and rs1481280 polymorphism and 
schizophrenia have been reported in a Japanese population [42]. No correlations were also 
detected between these ROCK1 genotypes and Brief Psychiatric Rating Scale scores, amounts 
of antipsychotics, or age at onset in that study.
Tables 1 and 2 show the significant and insignificant associations of ROCK polymorphisms 
with disease states.
Disease Significant association Ref. Insignificant association Ref.
Breast cancer Y405*, S1126* [10]
Lung cancer P1193S [10] rs11874761, rs8085504, rs2127958, rs17202375, 
rs288980
[11]
Gastric cancer G285* [12]
Colorectal cancer rs73963110, rs35996865 [13] rs35768389, rs73963110, rs2127958, rs288980 [14]
rs35996865 (in male patients) [14]
V1309* [43]
Clear cell renal cell 
carcinoma
rs35996865 [16] rs8089974, rs11874761 [16]
Tetralogy of Fallot rs288979, rs56085230 
(Tyr269Tyr)
[27] rs2292296 (Leu1097Phe), rs7237677, rs7227454, 
rs288989, rs45449301 (Ile432Val), rs288979, 
rs17202368, rs17202375, rs2271255 (Lys222Glu), 
rs1481280, rs8085504, rs398528, rs112165707 
(Ser595Ser), rs45562542 (Thr773Ser)
[27]
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Disease Significant association Ref. Insignificant association Ref.
Systemic sclerosis rs35996865 [28] rs112108028 (Pro1164Leu), rs1045144 [28]
Behçet’s disease rs73963110, rs111874856 
(Val355Ile), rs112130712 
(Lys1054Arg), rs112108028 
(Pro1164Leu)
[30] rs35996865, rs111312709 (Thr792Ala), rs2271255 
(Lys222Glu)
[30]
Primary open‐angle 
glaucoma
rs35996865 [32]
Ischemic stroke rs7239317, rs2127958, 
rs1481280, rs1006881, 
rs11874761, rs10083915, 
rs11873284
[33] rs288980 [33]
Obesity‐related 
metabolic syndrome
rs35996865 [34] rs73963110, rs112108028 (Pro1164Leu), 
rs111312709 (Thr792Ala),
[34]
Respiratory distress 
syndrome
rs2271255 (Lys222Glu), 
rs35996865
[35] rs73963110 [35]
Schizophrenia rs8085654, rs288980, rs1481280 [42]
Table 1. Significant and insignificant associations between ROCK1 variants and disease susceptibility.
Disease Significant association Ref. Insignificant association Ref.
Breast cancer rs2230774 (Thr431Asn) [9] rs1130757 (Arg83Lys) [9]
Gastric cancer S457N [12]
Colorectal cancer rs2290156, rs10178332, 
rs35768389, rs10929732, 
rs34945852
[13] rs965665, rs2230774, rs6755196, rs1515219 [13]
rs12692437, rs7563468, rs35768389, rs17463896, 
rs16857265
[14]
Mantle cell lymphoma rs2290156, rs965665, rs10178332, rs2230774 
(Thr431Asn), rs2230774 (Thr431Ser), 
rs6755196, rs726843
[15]
Hypertension rs2230774 (Thr431Asn) [17] rs2230774 (Thr431Asn) [19]
rs965665, rs10178332, 
rs6755196, rs10929732
[18] rs978906, rs2230774 (Thr431Asn), rs56304104 [20]
rs1868584 [23]
High‐altitude essential 
hypertension
rs978906, rs6753921, 
rs10495582, rs2230774 
(Thr431Asn)
[21] rs2290156, rs10167277, rs10929727, rs6716817, 
rs4477886, rs10929728
[21]
Preeclampsia rs12622447, rs10929728, rs1868584, rs6716817, 
rs2230774 (Thr431Asn), rs5829297, rs4027164, 
rs17366517
[22]
Arterial stiffness rs978906, rs2230774 
(Thr431Asn)
[24]
Vasospastic angina GTCTG haplotype [25] rs978906, rs2271621, rs2230774, rs1515219, 
rs3771106
[25]
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3. Structure or function of the ROCK enzymes affected by 
polymorphisms
The Thr431Asn polymorphism lies immediately carboxyl‐terminal to the start of the puta‐
tive coiled‐coil region and encodes an amino acid substitution in the predicted coiled‐coil 
domain of the protein, which is associated with ROCK2/ROCK2 parallel homodimerization 
Disease Significant association Ref. Insignificant association Ref.
Cardiac septal defects rs2230774 (Thr431Asn) [26]
Systemic sclerosis rs10178332 [28] rs2230774 (Thr431Ser), rs2230774 (Thr431Asn), 
rs35768389 (Asp601Val), rs726843, rs2290156, 
rs965665, rs6755196, rs10929732
[28]
Behçet’s disease rs35768389 (Asp601Val), 
rs1515219
[29] rs726843, rs2290156, rs965665, rs10178332, 
rs2230774, rs6755196, rs10929732, rs34945852
[29]
Rheumatoid arthritis rs1868584 [23]
Diabetic retinopathy rs2230774 (Thr431Asn), rs1130757 (Arg83Lys) [31]
Primary open‐angle 
glaucoma
rs2290156, rs965665, rs10178332, rs2230774 
(Thr431Asn), rs2230774 (Thr431Ser), 
rs6755196, rs726843
[32]
Ischemic stroke rs921322, rs8996, rs6753921, rs2230774, 
rs1515219, rs6716817, rs10203916, rs6755337, 
rs12622447
[33]
Obesity‐related metabolic 
syndrome
rs2230774 (Thr431Asn) [34] rs2230774 (Thr431Ser), rs726843, rs2290156, 
rs965665, rs10178332, rs6755196
[34]
Respiratory distress 
syndrome
rs726843, rs2290156, 
rs10178332, rs35768389 
(Asp601Val)
[35] rs1515219, rs965665, rs2230774 (Thr431Asn), 
rs6755196, rs10929732
[35]
Chronic kidney disease rs2230774 (Thr431Asn) [36]
Urinary albumin 
excretion
rs1515219, rs2290156 [37]
Overactive bladder rs2230774 (Thr431Asn) [38]
Idiopathic generalized 
epilepsy
rs2230774 (Thr431Asn) [39]
Migraine rs2230774 (Thr431Asn) [40]
Diabetes rs1868584 (with type‐1 
diabetes)
[23] rs2230774 (Thr431Asn), rs1130757 (Arg83Lys) [31]
High altitude pulmonary 
edema
rs10929728 [41] rs978906, rs6753921, rs2290156, rs10495582, 
rs2230774, rs10167277, rs13393192, rs10929727, 
rs6716817, rs4477886, rs41264193, rs12622447, 
rs10929728
[41]
Bipolar disorder rs1868584 [23]
Table 2. Significant and insignificant associations between ROCK2 variants and disease susceptibility.
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and Rho binding. Asp601Val polymorphism is also located on the coiled‐coil region. Because 
the dimeric structure of ROCK is essential for normal in vivo function [4, 5], changes in the 
coiled‐coil region could be hypothesized to effect dimerization, Rho binding, and thereby 
ROCK activation and phosphorylation of its substrates. Indeed, it has been demonstrated 
for rs2230774 (Thr431Asn) polymorphism that cells transfected with C allele constructs have 
significantly higher ROCK activities than those with A allele constructs [24]. Moreover, the 
average leukocyte ROCK activity was found to be highest in CC genotype, followed by AC 
and then lowest in AA [24]. Taken together, non‐synonymous polymorphism rs2230774 
(Thr431Asn) influences ROCK2 activity.
Three ROCK1 mutations (Y405*, S1126*, and P1193S) attenuate the autoinhibitory domain at 
the carboxy‐terminal end of the protein and enhance kinase activity [10]. In a colorectal cancer 
study, the ROCK1 mutation (typically c.3921delA leading to V1309*) is also predicted to par‐
tially delete the autoinhibitory domain [43]. ROCK1 nonsense mutation (G285*) introduces a 
premature stop codon at the 285th amino acid of ROCK1, leading to the truncation of ∼79% 
of ROCK1 [12]. The lack of a Rho‐binding domain by the ROCK1 mutation could impair the 
Rho/ROCK pathway [12]. Therefore, this mutation may cause the loss‐of‐function of ROCK1, 
because most of the functional domains, including the Rho‐binding domain, are truncated 
by the mutation. The rs56085230 (Tyr269Tyr) variant is synonymous and located within the 
kinase motif of the protein which might influence splicing [27]. ROCK2 gene rs978906 poly‐
morphism located at 3′‐UTR is predicted to influence microRNA(miR)‐1183 binding to ROCK2 
[24]. Thus, 3′‐UTR rs978906 polymorphism affects the ROCK2 protein synthesis by interfering 
miR‐1183 binding. miR‐1183 may modulate the disease states by fine tuning the ROCK2 pro‐
tein expression.
It has been reported that polymorphism can change the binding of the transcription factors to 
the gene. Pandey et al. [41] found that the variant allele rs10929728C of the ROCK2 gene binds to 
a transcription factor Nkx‐2, but the wild‐type allele rs10929728T binds to CdxA. Bioinformatic 
analysis also revealed that serum response factor, a transcription factor, binding site was found 
for the variant allele G of the ROCK2 gene rs10495582 polymorphism [21]. Serum response fac‐
tor is known to promote the transcriptional expression of ROCK2 [44]. In general, the structural 
or functional changes of the ROCK enzymes affected by polymorphisms are mostly unknown 
and require further studies.
4. Conclusions
There are some inconsistent results with the association studies, which can be explained in 
part by population stratification, ethnic differences, selection bias, genotyping errors, or other 
factors. The incomplete polymorphism coverage likely does not represent the entire gene and 
therefore may not fully describe the contribution of ROCK genes. In the future, systematic and 
large prospective studies or meta‐analysis are warranted to evaluate thoroughly the role of 
ROCK1 and ROCK2 genes in the genetic predisposition to disease. The structure or function 
of the ROCK enzymes affected by polymorphisms is mostly unknown, and functional studies 
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would be very helpful in elucidating the involvement of ROCK in disease pathogenesis. Further 
validations from larger, independent cohorts as well as perspective studies are also required to 
verify presently known associations in different ethnic groups. Furthermore, identification of 
functional mutations could potentially help in the development of ROCK‐specific therapies for 
ROCK‐related disease states.
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